Benefits and harms of antihypertensive treatment in low-risk patients mild hypertension
<p>Importance: Evidence to support initiation of pharmacologic treatment in low-risk patients with mild hypertension is inconclusive, with previous trials underpowered to demonstrate benefit. Clinical guidelines across the world are contradictory.</p><p> Objective: To examine wheth...
Главные авторы: | Sheppard, JP, Stevens, S, Stevens, R, Martin, U, Jonathan, M, Hobbs, FDR, McManus, R |
---|---|
Формат: | Journal article |
Опубликовано: |
American Medical Association
2018
|
Схожие документы
-
Benefits and harms of antihypertensive treatment in low-risk patients with mild hypertension
по: Sheppard, J, и др.
Опубликовано: (2018) -
Association of guideline and policy changes with incidence of lifestyle advice and treatment for uncomplicated mild hypertension in Primary Care: a longitudinal cohort study in the Clinical Practice Research Datalink
по: Sheppard, J, и др.
Опубликовано: (2018) -
Uncertainties: Which antihypertensive treatment is better in pregnancy for mild to moderate hypertension?
по: Ashworth, D, и др.
Опубликовано: (2022) -
The association between antihypertensive treatment and serious adverse events by age and frailty: a cohort study
по: Sheppard, JP, и др.
Опубликовано: (2023) -
Deprescribing antihypertensive medication in elderly adults - Reply
по: Sheppard, JP, и др.
Опубликовано: (2020)